Literature DB >> 20043655

Enhanced gold nanoparticle based ELISA for a breast cancer biomarker.

Adriano Ambrosi1, Federico Airò, Arben Merkoçi.   

Abstract

In this work, we developed an optical enzyme-linked immunosorbent assay (ELISA) immunoassay for the analysis of CA15-3 antigen, an important biomarker present in blood samples and useful for the follow-up of the medical treatment of breast cancer. Gold nanoparticles (AuNPs) were used as carriers of the signaling antibody anti-CA15-3-HRP (horseradish peroxidase) in order to achieve an amplification of the optical signal. In the range between 0 and 60 U/mL, the assay adopting AuNPs as an enhancer resulted in higher sensitivity and shorter assay time when compared to classical ELISA procedures. The application of AuNPs to the commercially available ELISA test can be useful to improve important immunoanalysis procedures where a more confident result is needed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20043655     DOI: 10.1021/ac902492c

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  45 in total

1.  Plasmonic ELISA for the detection of analytes at ultralow concentrations with the naked eye.

Authors:  Roberto de la Rica; Molly M Stevens
Journal:  Nat Protoc       Date:  2013-08-22       Impact factor: 13.491

2.  pH-tunable oxidase-like activity of cerium oxide nanoparticles achieving sensitive fluorigenic detection of cancer biomarkers at neutral pH.

Authors:  Atul Asati; Charalambos Kaittanis; Santimukul Santra; J Manuel Perez
Journal:  Anal Chem       Date:  2011-03-03       Impact factor: 6.986

Review 3.  Gold Nanoparticles for In Vitro Diagnostics.

Authors:  Wen Zhou; Xia Gao; Dingbin Liu; Xiaoyuan Chen
Journal:  Chem Rev       Date:  2015-06-26       Impact factor: 60.622

4.  DNA Linkers and Diluents for Ultrastable Gold Nanoparticle Bioconjugates in Multiplexed Assay Development.

Authors:  Samuel S Hinman; Kristy S McKeating; Quan Cheng
Journal:  Anal Chem       Date:  2017-03-24       Impact factor: 6.986

5.  Three-dimensional hierarchical plasmonic nano-architecture enhanced surface-enhanced Raman scattering immunosensor for cancer biomarker detection in blood plasma.

Authors:  Ming Li; Scott K Cushing; Jianming Zhang; Savan Suri; Rebecca Evans; William P Petros; Laura F Gibson; Dongling Ma; Yuxin Liu; Nianqiang Wu
Journal:  ACS Nano       Date:  2013-05-14       Impact factor: 15.881

6.  Extreme sensitive metasensor for targeted biomarkers identification using colloidal nanoparticles-integrated plasmonic unit cells.

Authors:  Arash Ahmadivand; Burak Gerislioglu; Asahi Tomitaka; Pandiaraj Manickam; Ajeet Kaushik; Shekhar Bhansali; Madhavan Nair; Nezih Pala
Journal:  Biomed Opt Express       Date:  2018-01-02       Impact factor: 3.732

7.  Electrochemical immunosensor for the breast cancer marker CA 15-3 based on the catalytic activity of a CuS/reduced graphene oxide nanocomposite towards the electrooxidation of catechol.

Authors:  Jafar Amani; Alireza Khoshroo; Mehdi Rahimi-Nasrabadi
Journal:  Mikrochim Acta       Date:  2017-12-26       Impact factor: 5.833

8.  Selective enrichment and sensitive detection of peptide and protein biomarkers in human serum using polymeric reverse micelles and MALDI-MS.

Authors:  Nadnudda Rodthongkum; Rajasekhar Ramireddy; S Thayumanavan; W Vachet Richard
Journal:  Analyst       Date:  2011-12-23       Impact factor: 4.616

9.  Dual-Readout Sandwich Immunoassay for Device-Free and Highly Sensitive Anthrax Biomarker Detection.

Authors:  Isaac N Larkin; Viswanadham Garimella; Gokay Yamankurt; Alexander W Scott; Hang Xing; Chad A Mirkin
Journal:  Anal Chem       Date:  2020-05-21       Impact factor: 6.986

10.  Probing the modulated formation of gold nanoparticles-beta-lactoglobulin corona complexes and their applications.

Authors:  Jiang Yang; Bo Wang; Youngsang You; Woo-Jin Chang; Ke Tang; Yi-Cheng Wang; Wenzhao Zhang; Feng Ding; Sundaram Gunasekaran
Journal:  Nanoscale       Date:  2017-11-23       Impact factor: 7.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.